Adjustments to the dosage or treatment approach, might be needed depending on how the patient responds and tolerates the therapy
Preclinical data on GLP-1 and GLP-1 RAs have displayed an impressive neuroprotective efficacy in stroke, Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases
Natural thymosin beta-4 has been associated in some studies with angiogenesis, cell migration, and tissue remodeling
We next investigated whether intracellular oxidation of l-valine followed by closure of K ATP -channels might be causing the depolarization
All medications come from licensed 503A compounding pharmacies, are HSA/FSA eligible, and are available to all 50 states without insurance or membership fees